Prolonged diabetic ketoacidosis and glycemic fluctuations associated with dapagliflozin: a case report

ConclusionProlonged DKA may be a result of SGLT-2 inhibition and individualized treatment and follow-up should be performed instead of standard DKA treatment. Also, we suggest that we need to evaluate endogenous insulin reserves of the patients before starting a SGLT-2I treatment. We believe that in order to raise awareness, these cases should be reported.

Source: International Journal of Diabetes in Developing Countries - May 17, 2020 Category: Endocrinology Source Type: research